Apparently, the University of Minnesota condones professionals such as Dr Charles Schulz behaving badly. Dr Schulz, who is currently in charge of the Seroquel XR trial for Borderline Personality Disorder and sponsored by the drug maker AstraZeneca has been given the gift of "looking the other way" by the University of Minnesota.
Reporter Andy Mannix writes:
Charles Schulz cleared in U of M investigation:
"The University of Minnesota has found no violations in an internal investigation into Department of Psychiatry Chair Dr. Charles Schulz, according a letter signed by Mark Rotenberg, the college's General Counsel.
A nine-page complaint filed with the Board of Regents in December 2009 initiated the probe, which accused Schulz of allowing pharmaceutical companies to use his name on studies he didn't write or research, burying negative research results, and violating ethics policies.
The U of M broke the complaint down into nine allegations, and cleared Schulz on all accounts.
"After careful examination of each allegation, we found no University policy violations or other improper conduct by Dr. Schulz warranting University action against him," writes Rotenberg.
Mike Howard, the author of the complaint, says he's not satisfied with Rotenberg's response.
"[Rotenberg] tries to white wash it all," says Howard. "That's certainly not the case, and I don't accept that."
Howard is a family friend of Dan Markingson, a 26-year-old who committed suicide while enrolled in a study through the U of M in 2004.
Markingson's mother, Mary Weiss, had tried to remove him from the study, arguing he was not mentally fit to consent. After the suicide, she discovered Schulz was a co-investigator on the study, and had received money from the drug company funding the research.
Weiss eventually sued Schulz and the U of M for malpractice, but a judge threw the case out before it ever saw a courtroom. "
Continue reading the City Pages article here.
---
Mike Howard has left comments on this blog and I want him and Mary, Dan's mother to know I am outraged at this, though we cannot expect justice from corrupt and unethical money driven pharma companies-- we certainly should expect more from the University of Minnesota, where the trial took place and continues w the Seroquel XR version, same doctor, same sponsor!
Dr Charles Schulz receives/d income from AstraZeneca, which speaks a 1000 words.
Subscribe to:
Post Comments (Atom)
Posts
2 comments:
Tsk Tsk. This is NOT good. So glad you did a post on it!
Not good at ALL...
Not surprising though--University of Minnesota does have to move ahead with validating the new market for Seroquel's extended release formula. No sense being slowing down by VALID ETHICS complaints, or holding researchers with broken moral compasses responsible for their unethical behavior. There ARE studies to do more people in, data to skew, and drug marketing strategies to implement; what is loss of life or integrity compared to that!?
Post a Comment